One expensive Healthcare stock – Japara Healthcare Ltd
Japara Healthcare Ltd (ASX: JHC) is aiming to attain a better position in the industry in order to leverage the growing demand at the back of increase in ageing population. The Cumulative Average Growth Rate of government funding during the fiscal 2008 to 2015 period was 8.6% and the government funding has been expected to rise going forward as ACFA estimates $33bn of capital funding is required to meet growth and replace obsolete stock. The group has bought four new land purchases in FY17 and built 445 new greenfield beds in the anticipation. During H1FY17, JHC had reported a revenue growth of 14.5% year on year (yoy) to $178.5 million while EBITDA grew by 3.6% yoy to $29.1 million. However, it has witnessed a decline of 9.9% yoy in net profit after tax to $14.6 million, impacted by Profke portfolio due to occupancy issues, while reported an overall average occupancy at 94.4% with focus on high quality resident care and innovation in service delivery. Further, the company’ projects are progressing well and the group has delivered four brownfield facilities during H1FY17 and four additional land sites secured in optimal metropolitan locations. With this, land has been secured for 10 of 11 greenfield projects which are targeted to provide over 1,100 places by FY20 to cater to the growing demand from Australia’s ageing population. Apart from this, company is commencing a $15 million refurbishment program and upgrading 13 facilities over the next two years, which is expected to provide progressive EBITDA uplift more than $4 million. While EBITDA is expected to grow at 7%-10% for FY17.
To read the complete report CLICK HERE. To get your free report CLICK HERE
Disclaimer DisclaimerThe advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people.Kalkine.com.au and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation.Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product.The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in: BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.CopyrightCopyright © 2015 Kalkine Pty Ltd ABN 34 154 808 312. No part of this website, or its content, may be reproduced in any form without the prior consent of Kalkine Pty Ltd.Kalkine is a trading name of Kalkine Pty Ltd ABN 34 154 808 312, which holds Australian Financial Services Licence No. 425376.